Searched for
PFIZER S COVID
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- In the shadow of COVID, health officials fight panic over Hantavirus outbreakA hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer shares sink after it resets 2024 Covid expectationsRevenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...
- Pfizer-BioNTech COVID shot 73.2% effective in kids under 5Pfizer and BioNTech's vaccine was authorized for children under 5 years of age in June, based on data that showed the vaccine generated a s...
- China approves use of Pfizer's COVID drug PaxlovidThe National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...
- Pfizer, BioNTech begin vaccine trial to target new strainThe study will have 1,420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech Covid vaccine or an Omic...
- Pfizer confirms COVID pill's results, potency versus omicronThe Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...
- Overseas indemnity new hurdle in India rollout of Pfizer Covid vaccineIndia is reluctant to provide such overseas indemnity but is in talks for an early resolution to facilitate the supply of the Pfizer-BioNTe...
- Received bid for Pfizer vaccine, says BMC; company deniesThe Municipal Corporation of Greater Mumbai said on Tuesday that it has received eight bids for the global tender floated by it for the pro...
- Discussions underway with GOI for supply of Pfizer-BioNTech COVID vaccine, says PfizerIn a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-B...
- Researchers urge delay in administering second dose of Pfizer's Covid-19 vaccine, cite strong dataIn its response, Pfizer said that alternative dosing regimens of its vaccine had not been evaluated yet and the decision to do that resided...
- Single dose of Pfizer COVID-19 vaccine provokes strong immune response: Study"This finding can help countries make informed decisions regarding vaccine policy -- for instance, whether those previously infected should...
- Pfizer withdraws vaccine plea as panel seeks India trial dataThe panel observed that incidents of serious adverse effects such as palsy and anaphylaxis and the causality of the events with the vaccine...
- US FDA nod may help speed up Pfizer vaccine rollout in India“India will have to give approval if it has to secure free doses of Pfizer vaccine from the Covax facility,” an official said. “Without giv...
- UK vaccine approval 'historic moment' in Covid-19 battle: Pfizer CEO"Today's Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19," said Pfizer CEO Albert Bourla.
- Pfizer says analysis shows 3.8% of Covid vaccine participants experienced fatigueIt said the updated analysis was based on 8,000 trial participants. Pfizer said in a previous analysis that 3.7 per cent of 6,000 volunteer...
Load More
